Mylan Mutual Funds | StatInvestor

Health Care & Life Sciences » Pharmaceuticals | Mylan

Mylan N.V. | Mutual Funds

Mutual Funds that own Mylan N.V.

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Vanguard Health Care Fund

30,606,342

5.94%

762,300

2.38%

06/30/2018

Vanguard Total Stock Market Index Fund

12,300,808

2.39%

46,522

0.06%

07/31/2018

Vanguard 500 Index Fund

9,331,404

1.81%

9,056

0.08%

07/31/2018

Vanguard Windsor I Fund

7,657,017

1.49%

1.47%

06/30/2018

FPA Crescent Fund

7,425,690

1.44%

1.57%

03/31/2018

iShares Nasdaq Biotechnology ETF

5,959,637

1.15%

-77,931

2.38%

09/06/2018

SPDR S&P 500 ETF

5,668,209

1.1%

65,751

0.08%

09/06/2018

Government Pension Fund - Global (The)

5,529,729

1.07%

1,311,058

0.03%

12/31/2017

Vanguard Institutional Index Fund

4,987,284

0.97%

5,798

0.08%

07/31/2018

PowerShares QQQ Trust

4,315,803

0.84%

-16,864

0.23%

09/05/2018

About Mylan

View Profile

Address	Building 4 Hatfield Hertfordshire AL10 9UL United Kingdom
Employees	-
Website	http://mylan.co.uk
Updated	07/08/2019
Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe, Rest of World, and Corporate or Other.